Home › Forums › Investments in the US › Summary of CNBC “Mad Money” Episodes › Mad Money: Key points from January 31, 2023 (Tuesday) episode
- This topic is empty.
-
AuthorPosts
-
-
2023-02-01 at 12:03 AM #6753
Jun Kurema (暮眞★潤)
KeymasterThis page contains summary of CNBC program “Mad Money w/ Jim Cramer” which was on air on Tuesday, January 31, 2023. It also contains links to CNBC sites which contain video clips and transcripts.
(1) Jim Cramer says we’re in a bull market, so buy on the dip (https://www.cnbc.com/2023/01/31/jim-cramer-says-were-in-a-bull-market-so-buy-on-the-dip.html)
- CNBC’s Jim Cramer on Tuesday told investors that the market is in bull mode, so declines represent opportunities to buy on a dip.
- Stocks rose on Tuesday, with the S&P 500 reaching its best January performance since 2019 on strong corporate earnings and softer-than-expected inflation data.
(2) Executive Interview: GM CEO Barra on the company’s pricing strategy (https://www.cnbc.com/video/2023/01/31/gm-ceo-barra-on-the-companys-pricing-strategy.html)
Cramer spoke with General Motors CEO Mary Barra on Tuesday.
Ticker: GM
(3) Jim Cramer says J.M. Smucker is the only new ‘dividend aristocrat’ worth buying (https://www.cnbc.com/2023/01/31/jim-cramer-says-jm-smucker-is-the-only-new-dividend-aristocrat-worth-buying.html)
- CNBC’s Jim Cramer said investors should consider adding J.M. Smucker stock to their shopping list.
- Nordson, C.H. Robinson and J.M. Smucker qualified for the S&P 500 Dividend Aristocrats and will be added to the index on Feb. 1, the S&P Dow Jones Indices said earlier this month.
Ticker: NDSN, CHRW, SJM
(4) Executive Interview: Pfizer CEO on the company’s full-year forecast (https://www.cnbc.com/video/2023/01/31/pfizer-ceo-on-the-companys-full-year-forecast.html)
Cramer spoke with Pfizer CEO Albert Bourla on Tuesday.
Ticker: PFE
(5) Cramer’s lightning round: CRISPR Therapeutics will work perfectly in this market (https://www.cnbc.com/2023/01/31/cramers-lightning-round-crispr-therapeutics-will-work-perfectly-in-this-market.html)
- Qualtrics International Inc: “I really like XM as a long-term growth play. … Let these guys do their work and then it’s a buy.”
- Clearfield Inc: “There’s an analyst that cut numbers and the stock fell apart. That was ridiculous.”
- CRISPR Therapeutics AG: “That’s one of those crazy science stocks that in this market will work perfectly.”
Ticker: XM, CLFD, CRSP
(6) [No Video Clip] Jim Cramer explains the inventory cycle (https://www.cnbc.com/video/2023/01/31/jim-cramer-explains-the-inventory-cycle.html)
Cramer gave his take on how the inventory cycle works across businesses and industries.
Other Stocks Discussed (calls with audience): Teladoc (TDOC) [stock will go higher]
Ref: Links to other sites that relate to episode of January 31, 2023
- Google Podcast (Sound)
- Internet Archive(Video & Texts per minute)
****************************
Previous episode Next Episode
-
-
AuthorPosts
- The topic ‘Mad Money: Key points from January 31, 2023 (Tuesday) episode’ is closed to new replies.